Compare PRPO & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRPO | KFFB |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Savings Institutions |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 42.7M |
| IPO Year | 2000 | 2004 |
| Metric | PRPO | KFFB |
|---|---|---|
| Price | $18.95 | $5.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 33.1K | 5.6K |
| Earning Date | 11-10-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 3.58% |
| EPS Growth | 92.15 | ★ 109.52 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $24,049,000.00 | $15,000.00 |
| Revenue This Year | $233.72 | N/A |
| Revenue Next Year | $22.61 | N/A |
| P/E Ratio | ★ N/A | $36.57 |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $17.79 | $4.00 |
| 52 Week High | $33.63 | $6.46 |
| Indicator | PRPO | KFFB |
|---|---|---|
| Relative Strength Index (RSI) | 38.17 | 59.97 |
| Support Level | N/A | $5.38 |
| Resistance Level | $24.78 | $6.15 |
| Average True Range (ATR) | 1.09 | 0.19 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 24.44 | 82.83 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.